Literature DB >> 28692581

Δ9-Tetrahydrocannabinol Suppresses Secretion of IFNα by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals.

Joseph E Henriquez1, Michael D Rizzo, Matthias A Schulz, Robert B Crawford, Peter Gulick, Norbert E Kaminski.   

Abstract

Plasmacytoid dendritic cells (pDCs) play a crucial role in host antiviral immune response through secretion of type I interferon. Interferon alpha (IFNα), a type I IFN, is critical for mounting the initial response to viral pathogens. A consequence of Human Immunodeficiency Virus-1 (HIV) infection is a decrease in both pDC number and function, but prolonged pDC activity has been linked with progression from HIV infection to the development of AIDS. Patients with HIV in the United States routinely use cannabinoid-based therapies to combat the side effects of HIV infection and antiretroviral therapy. However, cannabinoids, including Δ-tetrahydrocannabinol (THC), are well-characterized immunosuppressants. Here, we report that THC suppressed secretion of IFNα by pDC from both healthy and HIV+ donors through a mechanism involving impaired phosphorylation of interferon regulatory factor 7. These results suggest that THC can suppress pDC function during the early host antiviral response by dampening pDC activation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28692581      PMCID: PMC5527743          DOI: 10.1097/QAI.0000000000001449

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  66 in total

Review 1.  Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Authors:  Patrick Gannon; Muhammad Z Khan; Dennis L Kolson
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

Review 2.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

Review 3.  Potential interventions for HIV/AIDS wasting: an overview.

Authors:  D I Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

4.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Authors:  H Donaghy; A Pozniak; B Gazzard; N Qazi; J Gilmour; F Gotch; S Patterson
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

5.  The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir.

Authors:  Bradley W Kosel; Francesca T Aweeka; Neal L Benowitz; Starley B Shade; Joan F Hilton; Patricia S Lizak; Donald I Abrams
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

6.  Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.

Authors:  Valerio Chiurchiù; Cinzia Rapino; Emanuela Talamonti; Alessandro Leuti; Mirko Lanuti; Audrey Gueniche; Roland Jourdain; Lionel Breton; Mauro Maccarrone
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

7.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.

Authors:  Heather Donaghy; Brian Gazzard; Frances Gotch; Steven Patterson
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

8.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

Review 9.  The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.

Authors:  T Weichhart; M D Säemann
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

Review 10.  Interferon-alpha, immune activation and immune dysfunction in treated HIV infection.

Authors:  Lilian Cha; Cassandra M Berry; David Nolan; Allison Castley; Sonia Fernandez; Martyn A French
Journal:  Clin Transl Immunology       Date:  2014-02-28
View more
  10 in total

1.  Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.

Authors:  Joseph E Henriquez; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2019-02-23       Impact factor: 4.219

2.  SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.

Authors:  Patrick O'Connell; Yuliya Pepelyayeva; Maja K Blake; Sean Hyslop; Robert B Crawford; Michael D Rizzo; Cristiane Pereira-Hicks; Sarah Godbehere; Linda Dale; Peter Gulick; Norbert E Kaminski; Andrea Amalfitano; Yasser A Aldhamen
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

3.  Interferon-α-Mediated Activation of T Cells from Healthy and HIV-Infected Individuals Is Suppressed by Δ9-Tetrahydrocannabinol.

Authors:  Joseph E Henriquez; Michael D Rizzo; Robert B Crawford; Peter Gulick; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2018-07-19       Impact factor: 4.030

4.  Application of gene specific mRNA level determinations in individual cells using flow cytometry-based PrimeFlow™ in immunotoxicology.

Authors:  Joseph Henriquez; Jiajun Zhou; Jinpeng Li; Robert Crawford; Norbert Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-03       Impact factor: 4.219

5.  Δ9-Tetrahydrocannabinol (THC) Impairs CD8+ T Cell-Mediated Activation of Astrocytes.

Authors:  Joseph E Henriquez; Anthony P Bach; Karina M Matos-Fernandez; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2020-03-26       Impact factor: 4.147

Review 6.  Mini-review: The therapeutic role of cannabinoids in neuroHIV.

Authors:  Barkha J Yadav-Samudrala; Sylvia Fitting
Journal:  Neurosci Lett       Date:  2021-02-12       Impact factor: 3.046

Review 7.  Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.

Authors:  Attila Oláh; Zoltán Szekanecz; Tamás Bíró
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 8.  Immune Responses Regulated by Cannabidiol.

Authors:  James M Nichols; Barbara L F Kaplan
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

9.  Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.

Authors:  Alba Angelina; Mario Pérez-Diego; Jacobo López-Abente; Beate Rückert; Ivan Nombela; Mübeccel Akdis; Mar Martín-Fontecha; Cezmi Akdis; Oscar Palomares
Journal:  Mucosal Immunol       Date:  2021-09-21       Impact factor: 7.313

Review 10.  Cannabinoid-Induced Immunomodulation during Viral Infections: A Focus on Mitochondria.

Authors:  Cherifa Beji; Hamza Loucif; Roman Telittchenko; David Olagnier; Xavier Dagenais-Lussier; Julien van Grevenynghe
Journal:  Viruses       Date:  2020-08-11       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.